Cargando…

ANNUALIZED AND CUMULATIVE MEASURES OF ANTICHOLINERGIC EXPOSURE FOR RESEARCH AND CLINICAL APPLICATIONS

Medications with anticholinergic properties are commonly used by older adults despite being associated with dementia.The anticholinergic total standardized daily dose (TSDD) is a continuous measure of exposure that has been associated with an increased risk of dementia at values >1095 over ten ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalil, Hussein, Stachler, Eva, Alamer, Khalid, Ludlow, Jared, Campbell, Noll
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766780/ http://dx.doi.org/10.1093/geroni/igac059.2312

Ejemplares similares

Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure
por: Campbell, Noll L., et al.
Publicado: (2022)

An Evaluation of Longitudinal Measures of Anticholinergic Exposure for Application in Retrospective Administrative Data Analyses
por: Lozano-Ortega, Greta, et al.
Publicado: (2019)

Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale
por: Suh, Yewon, et al.
Publicado: (2020)

Measuring cumulative anticholinergic medicines burden in older Australian women
por: Parkinson, Lynne, et al.
Publicado: (2017)

Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020)

Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study
por: Szabo, Shelagh M, et al.
Publicado: (2019)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Anticholinergic syndrome in a patient with schizophrenia
por: Marco Estrada, O., et al.
Publicado: (2022)

Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls
por: Rosso, Andrea, et al.
Publicado: (2020)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2021)

The cognitive impact of anticholinergics: A clinical review
por: Campbell, Noll, et al.
Publicado: (2009)

The anticholinergic burden: from research to practice
por: Hilmer, Sarah N, et al.
Publicado: (2022)

PS95. Cognitive impairment of remitted depression in medication with anticholinergic activity
por: Maeshima, Hitoshi, et al.
Publicado: (2016)

Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia
por: Carter, Elizabeth, et al.
Publicado: (2020)

VULNERABILITY TO ANTICHOLINERGIC MEDICATION ASSOCIATED FRAILTY IN LOW-INCOME MINORITY OLDER ADULTS
por: Sargent, Lana, et al.
Publicado: (2022)

Structure and Change: New Developments in Research on Cumulative Dis/Advantage
por: Dannefer, William, et al.
Publicado: (2021)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan
por: Al-Azayzih, Ahmad, et al.
Publicado: (2023)

2393. Dimensions of Cumulative Antibiotic Exposure and Risk of Hospital Onset Clostridiodes Difficile
por: Song, Jiyoun, et al.
Publicado: (2019)

Prescribing Trends of Anticholinergic Drugs Between 1989 and 2017: A UK Biobank Study
por: Mur, Jure, et al.
Publicado: (2020)

Anticholinergic drugs and risk of dementia: case-control study
por: Richardson, Kathryn, et al.
Publicado: (2018)

Racial Disparities in Cognitive Function: The Roles of Cumulative Stress Exposures Across the Life Course
por: Chen, Ruijia, et al.
Publicado: (2020)

Cumulative trauma exposure comparison between non-refugee immigrants and locals with psychotic disorder
por: Trabsa Biskri, A., et al.
Publicado: (2023)

Cumulative Dis/Advantege, Structure, and Change: Three New Directions for CDA Research
por: Dannefer, William, et al.
Publicado: (2021)

Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

The effect of maternal prenatal cannabis exposure on offspring preterm birth: a cumulative meta-analysis
por: Adema, B. D., et al.
Publicado: (2023)

The Interplay between Vitamin D, Exposure of Anticholinergic Antipsychotics and Cognition in Schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2022)

Reduction in Measurement Error Confounds Cumulative Pollution Exposure
por: Barnett, Adrian
Publicado: (2008)

28th Annual Meeting of the Dysphagia Research Society
Publicado: (2021)

A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
por: Campbell, Noll L., et al.
Publicado: (2021)

Anticholinergic Drug Exposure Increases the Risk of Delirium in Older Patients Undergoing Elective Surgery
por: Herrmann, Matthias L., et al.
Publicado: (2022)

Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
por: Grossi, Carlota M., et al.
Publicado: (2019)

2022 Annual World Congress of the Pulmonary Vascular Research Institute
Publicado: (2022)

PS256. New drug therapy and the effect mechanism that the central anticholinergic drug Trihexylphenidyl reduces flashback in PTSD. The second report
por: Katsumasa, Sogo
Publicado: (2016)

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
por: Coupland, Carol A. C., et al.
Publicado: (2019)

Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults
por: Poonawalla, Insiya B., et al.
Publicado: (2023)

The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007)

Anticholinergic Drugs in Nonallergic Rhinitis
por: Naclerio, Robert
Publicado: (2009)

The mode of action of anticholinergics in asthma
por: Gosens, Reinoud, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l9etv8r81t1sdpr8r9cd670ghu